News & Analysis on Clinical Trial Services & Contract Research And Development
As GlaxoSmithKline, Bristol-Myers Squibb and Novartis are embroiled in alleged bribery and data falsification in Asia, CROs will have to a take a hard look at whether their investments in the region will pay off as quickly as they once thought.
Roche says increased staffing at its Swiss packaging hub has led to a CHF 100m ($106m) investment in a new training centre.
UK testing tech firm Copley scientific has launched new system designed to speed up dissolution media preparations.
Charles River Laboratories has partnered with eCRO Target Health and Theorem Clinical Research to support the transfer and validation of assays supporting the CROs’ preclinical programs.
A US FDA investigation of CRO PPD did not uncover any violations that might prompt a Form 483 for its work related to Bristol-Myers Squibb’s approved drug, Eliquis.
Albemarle says pricing pressure, lower volumes and reduced capacity utilisation negatively impacted its fine chemicals business in the second quarter.